The Partnership Will Utilize QuantifiCare’s DermaPix Mobile™ Image Management Application in Combination with FotoFinder’s DermLite handyscope™ device for Smartphones.
ATLANTA, GA – June 25th, 2021– QuantifiCare, the leading provider of validated clinical trial photography solutions, announced a strategic partnership with FotoFinder, the German medical imaging company, focused on bringing the latest in mobile dermoscopy solutions. The collaboration aims to provide study sites with a comprehensive mobile solution to capture, review and instantly transfer high-resolution digital dermoscopic images into the clinical trial workflow.
Dermoscopy or skin surface microscopy is a non-invasive method for the evaluation of suspicious skin lesions. As cutaneous diagnosis is often visually-based, dermoscopic images can provide clinicians with visual assistance in the examination of lesions and ultimately increase the accuracy and consistency of their diagnosis. Over recent years, the use of dermoscopy has expanded to other skin, hair, and nail disorders. In clinical trials, dermoscopic images are increasingly used as an adjuvant tool for efficacy evaluation, offering an objective and reliable early measure of pre and post treatment comparison.
FotoFinder-Dermlite’s handyscope offers the latest in high-quality mobile teledermoscopy devices. A simple and powerful mobile add-on, is compatible with all smartphones, allowing investigators to capture and record skin structures with amazing clarity. The handyscope™ features LED and polarized lighting, allowing for accurate visualization of deep skin structures. The handyscope presents as the ideal solution to enable remote assessment of dermoscopic images in virtual and hybrid clinical trials.
“We are excited about this partnership with FotoFinder. Their product perfectly complements our mobile solution, and we are convinced this synergy will greatly benefit clinical research” announced Jean-Philippe Thirion, CEO of QuantifiCare.
When used in combination with QuantifiCare’s mobile photography application for clinical trials, DermaPix, the solution intends to provide study sites with a seamless experience to capture both standard macro photography and dermoscopy images with a single device.
FotoFinder has been developing medical imaging systems since 1991 from their headquarters in Bavaria, Germany. The company is specialized in imaging technology for early skin cancer detection by means of Automated Total Body Mapping (ATBM) and digital dermoscopy, both powered by FotoFinder Artificial Intelligence. In addition, FotoFinder systems are used in clinical dermatology, hair consultation, aesthetics and clinical research.
For more information, visit: https://www.fotofinder-systems.com/
QuantifiCare is an Imaging CRO specialized in the management and analysis of 2D and 3D digital images in Phase I-IV multicenter and decentralized trials. With over 20 years of experience in clinical research and medical image processing, QuantifiCare has developed a strong expertise across the fields of dermatology, aesthetics, wound care and oncology. The company operates internationally from its offices in the USA, Europe, South America and Asia.
For more information, visit: https://www.quantificare.com/clinical-trials-photography/
Request more information: firstname.lastname@example.org
Keywords: dermatology, dermoscopy, skin imaging, clinical trials,
Copyright QuantifiCare 2021